LEADER 01839nam  2200433Ka 450 
001 9910695986203321
005 20070711172242.0
035   $a(CKB)5470000002373935
035   $a(OCoLC)154380830
035   $a(EXLCZ)995470000002373935
100   $a20070711d2007      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCardiac resynchronization therapy and implantable cardiac defibrillators in left ventricle systolic dysfunction$b[electronic resource] /$fprepared by University of Alberta Evidence-based Practice Center ; investigators, Finlay A. McAlister ... [and others]
210  1$a[Rockville, Md.] :$c[Agency for Healthcare Research and Quality],$d[2007]
215   $a1 volume (various pagings) $cdigital, PDF file
225 1 $aEvidence report/technology assessment ;$vno. 152
225 1 $aAHRQ publication ;$vno. 07-E 009
300   $aTitle from title screen (viewed on July 11, 2007).
300   $a"June 2007."
606   $aCardiac pacing
606   $aImplantable cardioverter-defibrillators
606   $aCongestive heart failure$xTreatment
606   $aHeart$xLeft ventricle$xDiseases$xTreatment
615  0$aCardiac pacing.
615  0$aImplantable cardioverter-defibrillators.
615  0$aCongestive heart failure$xTreatment.
615  0$aHeart$xLeft ventricle$xDiseases$xTreatment.
701   $aMcAlister$b Finlay$01422547
712 02$aUniversity of Alberta Evidence-based Practice Center.
712 02$aUnited States.$bAgency for Health Care Policy and Research.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695986203321
996   $aCardiac resynchronization therapy and implantable cardiac defibrillators in left ventricle systolic dysfunction$93547242
997   $aUNINA